Cargando…

An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years

Detalles Bibliográficos
Autor principal: Muller, Madeleine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378173/
https://www.ncbi.nlm.nih.gov/pubmed/32148060
http://dx.doi.org/10.4102/safp.v62i1.5092
_version_ 1783740787317538816
author Muller, Madeleine
author_facet Muller, Madeleine
author_sort Muller, Madeleine
collection PubMed
description
format Online
Article
Text
id pubmed-8378173
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-83781732021-09-03 An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years Muller, Madeleine S Afr Fam Pract (2004) CPD Article AOSIS 2020-02-17 /pmc/articles/PMC8378173/ /pubmed/32148060 http://dx.doi.org/10.4102/safp.v62i1.5092 Text en © 2020. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle CPD Article
Muller, Madeleine
An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
title An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
title_full An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
title_fullStr An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
title_full_unstemmed An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
title_short An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
title_sort overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
topic CPD Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378173/
https://www.ncbi.nlm.nih.gov/pubmed/32148060
http://dx.doi.org/10.4102/safp.v62i1.5092
work_keys_str_mv AT mullermadeleine anoverviewofthenewrifampicinresistanttuberculosisregimensavailableatdecentraliseddrugresistanttuberculosissitesforpersonsolderthansixyears
AT mullermadeleine overviewofthenewrifampicinresistanttuberculosisregimensavailableatdecentraliseddrugresistanttuberculosissitesforpersonsolderthansixyears